| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 13,600 | 14,000 | 13:04 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| NEXSTIM Aktie jetzt für 0€ handeln | |||||
| 16.09. | Nexstim Oyj: Nexstim Receives NBS 5+ System Order from Therapy Customer in United States | 77 | GlobeNewswire (Europe) | Press release, Helsinki, 16 September 2025 at 9 AM (EEST)
Nexstim Receives NBS 5+ System Order from Therapy Customer in United States
Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an... ► Artikel lesen | |
| 15.08. | Nexstim Oyj: Nexstim Plc Half-year Report January 1 - June 30, 2025 (unaudited) | 98 | GlobeNewswire (Europe) | NEXSTIM PLC HALF-YEAR REPORT JANUARY 1 - JUNE 30, 2025 (UNAUDITED)
Company announcement, Helsinki, August 15, 2025 at 9 am (EEST)
NEXSTIM ACCELERATED GROWTH AND IMPROVED PROFITABILITY IN THE FIRST HALF... ► Artikel lesen | |
| 08.08. | Nexstim Oyj: Nexstim Receives NBS System 5 Order from India | 293 | GlobeNewswire (Europe) | Press release, Helsinki, 8 August 2025 at 10 AM (EEST)
Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an order for an NBS System 5 from an Indian distributor.
The end customer is a hospital... ► Artikel lesen | |
| 30.06. | Nexstim Oyj: Nexstim Plc Signs Exclusivity Agreement with Sinaptica Therapeutics, Inc. as Part of Planned Alzheimer's Collaboration | 87 | GlobeNewswire (Europe) | Company Announcement, Helsinki, 30 June 2025 at 9 AM (EEST)
Nexstim Plc Signs Exclusivity Agreement with Sinaptica Therapeutics, Inc. as Part of Planned Alzheimer's Collaboration
Nexstim Plc (NXTMH:HEX)... ► Artikel lesen | |
| 23.06. | Nexstim Oyj: Nexstim Receives NBS System 5 Order from a University Hospital in Germany | 187 | GlobeNewswire (Europe) | Press release, Helsinki, 23 June 2025 at 9 AM (EEST)
Nexstim Receives NBS System 5 Order from a University Hospital in Germany
Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an order... ► Artikel lesen | |
| 05.05. | Nexstim Oyj: Nexstim Plc Business Update Q1 2025 | 238 | GlobeNewswire (Europe) | Press release, Helsinki, 5 May 2025, at 9 AM (EEST)
Nexstim Plc Business Update Q1 2025
Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") announces the key highlights of the Company's business operations... ► Artikel lesen | |
| 27.02. | Nexstim Oyj: Nexstim Plc's Financial Statements Bulletin 2024 | 259 | GlobeNewswire (Europe) | Company announcement, Helsinki 27 February 2025 at 9 am (EET)
NEXSTIM PLC'S FINANCIAL STATEMENTS BULLETIN 2024
NEXSTIM CONTINUED PROFITABLE GROWTH AND SIGNED SIGNIFICANT PARTNERSHIPS
July-December 2024
The... ► Artikel lesen | |
| 15.01. | Nexstim Oyj: Insider Information: Nexstim Plc and Sinaptica Therapeutics, Inc. Announce Initiation of Co-Development of the SinaptiStim Precision Neuromodulation System to treat Alzheimer's Disease | 141 | GlobeNewswire (Europe) | Company Announcement, Helsinki, 15 January 2025 at 9 AM (EET)
Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") and Sinaptica Therapeutics, Inc. ("Sinaptica"), a clinical-stage company leading the development... ► Artikel lesen | |
| 29.11.24 | Nexstim Oyj: Inside Information: Nexstim Plc and Brainlab AG initiate collaboration by signing development and distributorship cooperation agreement and agreeing on a maximum of EUR 5,095,000 equity investment into Nexstim | 374 | GlobeNewswire (Europe) | Company Announcement, Helsinki, 29 November 2024 at 9:15 AM (EET)
Inside Information: Nexstim Plc and Brainlab AG initiate collaboration by signing development and distributorship cooperation agreement... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Announces Voting Results from Special Meeting of Stockholders | -- Evofem Shareholders Did Not Approve the Merger with Aditxt --
-- Evofem Pivots to Target National Listing for Stock, Growth Capital to Catalyze Net Sales... ► Artikel lesen | |
| VERU | 3,790 | +2,43 % | Veru Inc.: Veru Reports Fiscal 2025 Third Quarter Financial Results and Clinical Program Progress | --Company reported positive efficacy and safety data from Phase 2b QUALITY study showing enobosarm added to semaglutide led to preservation of muscle, greater fat loss, and fewer gastrointestinal... ► Artikel lesen | |
| FRESENIUS | 49,000 | +0,06 % | Fresenius zieht weiter an - Analyst hebt den Daumen | Die Aktie von Fresenius kann nach dem Rücksetzer in der vergangenen Woche zum Wochenstart erneut zulegen. Im 3-Monatsvergleich ist das Papier sogar der beste Wert im deutschen Leitindex DAX vor RWE... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 49,530 | +0,34 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 47,090 | +1,29 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 34,990 | +1,13 % | PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance | SAN JOSE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| GERRESHEIMER | 29,040 | +3,94 % | KAUFCHANCE!? Gerresheimer Absturz! Renk Korrektur! Nakiki Aktie auf den Bitcoin-Spuren von Strategy und Metaplanet! | Die Nakiki SE elektrisiert mehr und mehr Aktieninvestoren und die Bitcoinwelt. Auf den Spuren von Strategy will man zum ersten deutschen Bitcoin Treasury Unternehmen im regulierten Markt werden. Rund... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 45,860 | -2,88 % | BERNSTEIN RESEARCH stuft CARL ZEISS MEDITEC AG auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Carl Zeiss Meditec auf "Outperform" mit einem Kursziel von 56,40 Euro belassen. Mit der Reifung des Gesundheitssystems... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 33,520 | +0,06 % | Jefferies hebt Kursziel für BrightSpring Health wegen starker Fundamentaldaten auf 36 US-Dollar an | ||
| OTTOBOCK | 70,00 | +1,16 % | Ottobock verdoppelt die Neuromotorik-Wette: 10 Mio. € als Cornerstone | Ottobock SE & Co. KGaA baut ihr Engagement bei ONWARD Medical N.V. aus - und bleibt größter Anteilseigner. Der NeuroTech-Spezialist sammelte am 24. Oktober 2025 im Zuge einer Kapitalerhöhung insgesamt... ► Artikel lesen | |
| UNITEDHEALTH | 312,00 | +0,10 % | Nächstes Beben: Molina Healthcare crasht - UnitedHealth schwach | Die US-Krankenversicherer kommen nicht zur Ruhe. Am Mittwochabend hat der Gesundheitsdienstleister Molina Healthcare die Anleger mit enttäuschenden Zahlen erneut verunsichert. Die Aktie brach daraufhin... ► Artikel lesen | |
| GENEDX | 128,87 | +3,08 % | 4 Analysts Assess GeneDx Holdings: What You Need To Know | ||
| ALIGNMENT HEALTHCARE | 17,500 | +1,21 % | Alignment Healthcare USA, LLC: Alignment Health Plan Joins Forces with Suvida Healthcare to Expand Bilingual Care, Access for Arizona Seniors | ||
| ONCOLOGY INSTITUTE | 4,750 | +2,48 % | The Oncology Institute Welcomes Dr. Jeff Langsam as Chief Clinical Officer | CERRITOS, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) ("TOI"), one of the largest value-based oncology groups in the United States, announced today that Dr.... ► Artikel lesen | |
| RXSIGHT | 8,610 | +2,14 % | Pre-market Movers: Basel Medical Group, SOBR Safe, ProKidney, RxSight, Mustang Bio | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green Basel Medical Group Ltd (BMGL) is up over 88% at... ► Artikel lesen |